Telmisartan Dosing for Adults with Hypertension
The recommended dosage of telmisartan for adults with hypertension is 40 mg once daily as the starting dose, with a dose range of 20-80 mg once daily based on blood pressure response. 1
Initial Dosing
- The usual starting dose is 40 mg once daily 1
- Lower starting dose of 20 mg may be considered for patients with volume depletion, those on hemodialysis, or those taking diuretics 1
- No initial dosage adjustment is necessary for elderly patients or those with renal impairment 1
Dose Titration
- Blood pressure response is dose-related over the range of 20 to 80 mg 1
- Most of the antihypertensive effect is apparent within 2 weeks of starting therapy 1
- Maximal blood pressure reduction is generally attained after 4 weeks of treatment 1
- Dose adjustments should be made no more frequently than every 1-2 weeks, based on blood pressure response 2
Target Dosing
- Maximum effective dose is typically 80 mg once daily 1, 2
- For cardiovascular risk reduction, 80 mg once daily is the recommended dose 1
- Doses higher than 80 mg daily have not shown additional benefit in clinical trials 2, 3
Administration Considerations
- Telmisartan may be administered with or without food 1
- Can be administered with other antihypertensive agents when combination therapy is needed 1
- For stage 2 hypertension (BP ≥140/90 mmHg with BP more than 20/10 mmHg above target), initiation with combination therapy including telmisartan is recommended 4
Monitoring Parameters
- Blood pressure should be monitored regularly during dose titration 4
- Follow-up evaluation of adherence and response to treatment should occur at monthly intervals until control is achieved 4
- Monitor renal function and serum potassium, especially in patients with renal impairment 5
Special Considerations
- Telmisartan is contraindicated in patients with known hypersensitivity to the medication 1
- Do not co-administer with aliskiren in patients with diabetes 1
- Avoid use during pregnancy due to risk of fetal harm 1
- Patients on dialysis may develop orthostatic hypotension; blood pressure should be closely monitored 1
Common Pitfalls
- Underdosing: Many patients remain on suboptimal doses, which may result in inadequate blood pressure control 3
- Failure to recognize the full antihypertensive effect may take up to 4 weeks 1, 3
- Inappropriate discontinuation due to minor increases in creatinine, which may be expected and often not clinically significant 5, 6
- Combining telmisartan with ACE inhibitors is not recommended due to increased risk of adverse effects 1
Treatment Algorithm
- Start with telmisartan 40 mg once daily for most patients 1
- If blood pressure goal is not achieved after 2-4 weeks, increase to 80 mg once daily 1, 3
- If blood pressure remains uncontrolled on maximum dose, add a second antihypertensive agent from a different class (preferably a thiazide diuretic or calcium channel blocker) 4
- For stage 2 hypertension, consider initial combination therapy with telmisartan plus another agent 4